Corteva, Inc.

Corteva, Inc.

CTVA

$11.78

Updated: 03/11/2026, 19:39:07

Market Cap
$7.86B
Sector
Basic Materials
Industry
Agricultural Inputs
Country
US

No historical data available

Company Profile

Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.

USD
NYSE
CEO: Luke C. Kissam
Employees: 21,500
https://www.corteva.com
Asset Summaries
Latest generated summaries for CTVA

No summaries found.

Detailed business
Evidence-backed facts extracted from the latest official annual filing.
CTVA-10-k-fy2025.html4.5 MBtext/htmlENFiled 12/02/2026Period ended 31/12/2025

Business monitoring

Reported and calculated KPIs plus operational exposure disclosed in the FY 2025 filing.

Evidence-backed · 41 KPI observations

Revenue

N/A

FY — · Reported

Net income

$1.1B

FY 2025 · Reported

Gross margin

N/A

FY — · Reported

Free cash flow

N/A

FY — · Reported

R&D intensity

N/A

FY — · Reported

Share repurchases

$1.1B

FY 2025 · Reported

Earnings and cash generation
USD billions, directly sourced from inline XBRL; free cash flow is operating cash flow less capex.
Profitability and reinvestment
Margins and R&D as a percentage of revenue.
Top products and services
Products and services mentioned in the filing; a quantitative sales breakdown was not disclosed.

Other offerings mentioned without separate sales

Crop Protection major product lines and brands
Enlist E3 soybean trait leadership

Area-level product sales are displayed only when the filing reports a product × geography breakdown. Regional totals are not allocated across products by estimation.

Geographic footprint
What the filing identifies, separated by location role so partner manufacturing is not presented as Apple-owned factories.
1 named headquarters
0 manufacturing countries
0 individually named factories

Map layer

Pins show disclosed operations. The heatmap colors the filing’s reported geographies; regional figures shade the region and are not estimates for each country.

No reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosure
Named headquarters Manufacturing partner country

Only locations and quantities explicitly supported by the filing are displayed. A country-level manufacturing percentage or product allocation is shown only when the source discloses it; materiality scores are never presented as production shares.

How the business makes money

Seed segment distribution channels

Four differentiated channels: Pioneer agency model, regional seed brands, retail, and third-party licensing/distribution

98%
Source evidence
“which includes four differentiated channels: Pioneer agency model, regional seed brands, retail, as well as third parties through licensing and distribution channels.”

Crop Protection segment description

Crop Protection: leader in global herbicides, insecticides, nitrogen stabilizers, pasture & range herbicides, biologicals

98%
Source evidence
“The segment is a leader in global herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products.”

Seed segment description

Seed: global leader in commercial seed; leads North America corn/soybeans, Europe corn/sunflower, and corn in Brazil, India, South Africa, Argentina

98%
Source evidence
“The segment is a leader in many key seed markets, including North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn.”

Crop Protection segment description

Crop Protection: weed, insect, disease control plus nitrogen management and seed-applied technologies; leader in global herbicides, insecticides, nitrogen stabilizers and biologicals

97%
Source evidence
“The company is a leader in global herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products.”

Reporting units: Seed and Crop Protection

Goodwill is tested at reporting-unit level; reporting units are Seed and Crop Protection.

95%
Source evidence
“The company’s reporting units are Seed and Crop Protection.”

Customer financing programs with financial institutions across regions

Corteva has annual agreements with financial institutions financing select seed and crop protection customers in the US, Latin America, Europe and Asia; Corteva typically guarantees the credit.

95%
Source evidence
“Corteva has additional agreements with financial institutions to establish programs that provide financing for select customers of Corteva's seed and crop protection products in the United States, Latin America, Europe and Asia.”

Pioneer agency model

Pioneer agency model: direct sales to farmers via independent sales representatives, unique to Corteva

97%
Source evidence
“The Pioneer agency model is unique to Corteva and represents sales made directly to farmers primarily via independent sales representatives.”

Retail and licensing channels

Retail storefronts (distributors, ag cooperatives, dealers) plus out-licensing of traits and germplasm to third parties

95%
Source evidence
“may include sales to distributors, agricultural cooperatives, and dealers. Finally, Corteva out-licenses traits and germplasm to third parties.”

Crop Protection major product lines and brands

Six product lines: Insect & Nematode Management, Disease Management, Weed Control, Nitrogen Management, Biologicals, Other (LANDVisor) with named brands

97%
Source evidence
“The Crop Protection segment’s major brands and technologies, by key product line, are listed below”

Enlist E3 soybean trait leadership

Enlist E3 is the leading herbicide tolerance trait for US soybeans; Conkesta E3 growth in Brazil via licensing

95%
Source evidence
“Enlist E3® technology has rapidly become the leading herbicide tolerance trait for soybeans in the United States. In Brazil, growth in adoption of Conkesta E3® soybean technology is being pursued through licensing.”

Principal 2025 export markets outside the US

2025 sales outside the US principally to customers in Brazil, Eurozone countries, and Canada

95%
Source evidence
“Corteva’s sales outside the United States in 2025 were principally to customers in Brazil, Eurozone countries, and Canada.”

Segment net sales and operating EBITDA 2023-2025

Seed FY2025 sales $9,898M, EBITDA $2,636M; Crop Protection $7,503M sales, $1,350M EBITDA; total EBITDA $3,986M vs $3,491M in 2024 and 2023

99%
Source evidence
“Net sales$9,898 $7,503 $17,401 Segment operating EBITDA2,636 1,350 3,986”

Operations and dependencies

Crop Protection key raw materials

Key raw materials: chlorinated pyridines derivatives, specialty intermediates, technical grade active ingredients, chlorine, seed treatments

96%
Source evidence
“The key raw materials and supplies for the Crop Protection segment include chlorinated pyridines derivatives, specialty intermediates and technical grade active ingredients, chlorine, and seed treatments.”

Crop Protection contract manufacturing and regional formulation

Contract manufacturers domestically and internationally; inputs sourced globally; formulation close to end customers

93%
Source evidence
“The company relies on contract manufacturers, both domestically and internationally, to produce certain inputs or key components for its product formulations.”

Seed segment third-party growers

Seed production relies on third-party contract growers globally; seeds conditioned/packaged in own and third-party contract plants

95%
Source evidence
“The company contracts with third-party growers globally... The company’s third-party growers are an important part of its supply chain.”

Crop Protection supplier concentration and contracts

Long-term contracts with multiple suppliers (sometimes minimum purchase commitments); certain important raw materials from a few major suppliers

94%
Source evidence
“Certain important raw materials are supplied by a few major suppliers.”

Positioning and strategy

Stoller and Symborg acquisitions

Completed acquisitions of Stoller and Symborg; acquisition-related costs excluded from segment EBITDA

92%
Source evidence
“transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg”

Biologicals growth via acquisitions and Corteva Catalyst

Corteva evaluates acquisitions and strategic technology investments through its Corteva Catalyst platform, including growth in biologicals.

90%
Source evidence
“including its growth in biologicals, Corteva could fail to achieve expected increases in revenues and operating results”

Seed production model flexibility

Owned plants plus contract growers provide flexibility to react to geographic demand changes while minimizing costs

88%
Source evidence
“By striking a balance between owning production facility assets directly and contracting with third-party growers, the company believes it is best able to maintain flexibility to react to demand changes unique to each geography while minimizing costs.”

Seed R&D data digitization and analytics

Continued investment in data digitization/analytics to drive supply chain responsiveness and R&D advancement

90%
Source evidence
“The company continues to invest in and build capabilities that drive value via data digitization and analytics.”

Crop Protection growth strategy

Grow via differentiated sustainable offerings including biologicals, operational excellence, disciplined M&A

92%
Source evidence
“plans to grow through its differentiated, sustainable product offerings, including biologicals, with a focus on operational excellence and disciplined mergers and acquisitions.”

Risks, financing, and outlook

Input cost volatility and mitigation

Volatile raw material and production input costs; hedged with derivatives and long-term contracts, offset by pricing and productivity

95%
Source evidence
“Corteva purchases raw materials through negotiated long-term contracts to minimize the impact of price fluctuations. Corteva also enters into over-the-counter and exchange traded derivative commodity instruments to hedge its exposure to price fluctuations on certain purchases.”

Crop Protection Operations Strategy Restructuring Program - Pittsburg, CA exit

2023 pre-tax non-cash impairment of $152M ($92M operating lease assets, $60M PP&E) from plan to exit Pittsburg, CA production and select manufacturing lines

96%
Source evidence
“the company plans to exit its production activities at its site in Pittsburg, California, as well as cease operations in select manufacturing lines at other locations”

Environmental liabilities including PFAS and EIDP legacy exposure

Environmental liabilities including PFAS and legacy EIDP discontinued/divested business remediation exposure

95%
Source evidence
“Environmental and health and safety laws, regulations and standards, including those with respect to PFAS and other substances, expose Corteva to the risk of substantial costs and liabilities, including liabilities associated with Corteva’s business and the discontinued and divested businesses and operations of EIDP.”

Customer credit/financing program risk

Corteva extends customer financing with credit terms generally under one year aligned to the growing season; downturns or adverse growing conditions can impair customer repayment.

95%
Source evidence
“Corteva offers its customers financing programs with credit terms generally less than one year from invoicing in alignment with the growing season.”

Climate change and weather seasonality risk

Climate change and unpredictable seasonal/weather factors can impact sales, seed costs, inventory write-offs, and demand mix

95%
Source evidence
“Climate change may increase the frequency or intensity of extreme weather such as storms, floods, heat waves, droughts and other events that could affect the quality, volume and cost of seed produced for sale as well as demand and product mix.”

Antitrust/competition regulatory scrutiny including Food Supply Chain Security Task Forces

December 6, 2025 executive order on food supply chain competition; pending FTC and state attorney general lawsuits against Corteva

95%
Source evidence
“On December 6, 2025, President Trump issued an executive order titled “Addressing Security Risks from Price Fixing and Anti‑Competitive Behavior in the Food Supply Chain.””

Regulatory approval risk for seed and crop protection products

Regulatory approvals for biotech traits and crop protection products are lengthy and unpredictable; non-compliance can restrict market sales

95%
Source evidence
“The regulatory approvals process is lengthy, costly, complex and in some markets unpredictable, with requirements that can vary by product, technology, industry and country.”

Government agricultural policy and subsidy risk

Changes in farm subsidies and programs such as the U.S. Farm Bill may affect grower demand

90%
Source evidence
“government programs that provide financial support or create incentives for farmers, including those established by the U.S. Farm Bill, can be temporary in nature, or may be modified or discontinued.”

Sustainability sentiment could affect stock price and capital access

Failure to achieve sustainability commitments cost-effectively and on time could damage reputation, customer and investor relationships, and access to financing.

90%
Source evidence
“Failure to achieve its sustainability commitments within the expected timeframes and cost effectively could damage Corteva's reputation, customer and investor relationships, or its access to financing.”

Public acceptance risk for biotechnology and crop protection

Public understanding and acceptance of biotechnology and agricultural products can affect sales and results

90%
Source evidence
“The degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products and technologies can affect Corteva’s sales and results of operations”

Pandemic/epidemic supply chain and demand risk

Future pandemics could disrupt Corteva's global supply chain, routes to market, and customer demand, increasing product or distribution costs.

90%
Source evidence
“Future pandemics or epidemics and resulting illness, travel restrictions and workforce and operational disruptions could impact Corteva's global supply chain, its operations and its routes to market”

Industrial espionage and cybersecurity incidents have occurred

Target of industrial espionage/cyber-attacks; incidents resulted in unauthorized access to certain confidential business information

90%
Source evidence
“Corteva has determined that these incidents have resulted, and could result in the future, in unauthorized parties gaining access to certain confidential business information.”

Competition, generic entry and patent expiry risk

Patent expiry and at-risk generic launches can lose a major portion of product revenues; digital purchase models create price pressure

90%
Source evidence
“Upon the loss or expiration of patent protection for one of Corteva’s products or of a product that Corteva licenses, or upon the “at- risk” launch (despite pending patent infringement litigation against the generic product) by a generic manufacturer of a generic version of one of Corteva’s patented products or of a product that Corteva licenses, Corteva can lose a major portion of revenues for that product”

Pipeline commercialization risk

Successful development and commercialization of pipeline products necessary for growth; transitions take years and resistance may outpace new technologies

90%
Source evidence
“Commercial transitions to the company’s new technologies can take several years to complete, and weed and insect resistance may develop faster than Corteva can respond with new technologies or enhancements to existing technologies.”

Intellectual property challenges including with Inari

Competitors are increasingly challenging Corteva's intellectual property positions, including challenges with Inari, with highly uncertain outcomes.

90%
Source evidence
“Competitors are increasingly challenging intellectual property positions and the outcomes to these challenges, including those with Inari, can be highly uncertain”

Regulatory approvals and biotechnology acceptance

Key forward-looking risks include failure to obtain or maintain regulatory approvals, public acceptance of biotechnology products, and compliance with competition/antitrust laws.

90%
Source evidence
“(i) failure to obtain or maintain the necessary regulatory approvals for some of the company's products”

Sourcing flexibility risk

Demand shifts, local raw material shortages, or capacity constraints may force alternative-geography sourcing

88%
Source evidence
“Shifts in customer demand, reduced local availability of raw materials, and/or production capacity constraints may, at times, necessitate sourcing from an alternative geography.”

US government agency funding and staff reductions

Corteva flags recent funding and staff reductions at U.S. government agencies as a risk factor.

85%
Source evidence
“(x) risks related to recent funding and staff reductions at U.S. government agencies;”

Distribution platform risk and counterfeit products

Risks include a competitor establishing an intermediary distribution platform and the effect of counterfeit products.

85%
Source evidence
“(ix) competitor's establishment of an intermediary platform for distribution of the company's products;”

Material exposure graph

Seed and crop protection regulatory approvals
Regulatory Exposure

Failure to obtain/maintain registrations for seeds and crop protection products can restrict sales, cause recalls, crop destruction, and trade disruption.

Relevance 90·Dependency 85·Confidence 95
Source evidence
“The regulatory approvals process is lengthy, costly, complex and in some markets unpredictable, with requirements that can vary by product, technology, industry and country.”
Crop Protection products
Revenue Exposure

Crop Protection segment contributed $7,503M FY2025 net sales (~43% of total) and is undergoing restructuring including the Pittsburg, CA production exit.

Relevance 90·Dependency 80·Confidence 95
Source evidence
“Net sales$9,898 $7,503 $17,401”
Weather and climate
Demand Driver

Weather drives pest/disease presence, seed yields, quality, cost, and crop protection demand; climate change amplifies volatility.

Relevance 85·Dependency 80·Confidence 95
Source evidence
“Weather factors can affect the presence of disease and pests on a regional basis and, accordingly, can positively or adversely affect the demand for crop protection products”
Agricultural biotechnology regulatory approvals
Regulatory Exposure

Product commercialization depends on regulatory approvals and public acceptance of biotechnology products.

Relevance 85·Dependency 75·Confidence 90
Source evidence
“(i) failure to obtain or maintain the necessary regulatory approvals for some of the company's products; (ii) failure to successfully develop and commercialize the company's pipeline;”
Corteva agricultural customers using financing programs
Customer Exposure

Corteva extends seasonal credit to customers; customer defaults in downturns or poor growing regions would hurt results.

Relevance 85·Dependency 75·Confidence 90
Source evidence
“Corteva regularly extends credit to its customers to enable them to purchase seed or crop protection products at the beginning of the growing season.”
Brazil
Currency Exposure

Brazil is a principal 2025 non-US sales market and the Brazilian real is the largest currency exposure; inflation/downturn there could reduce demand.

Relevance 85·Dependency 70·Confidence 95
Source evidence
“Corteva’s sales outside the United States in 2025 were principally to customers in Brazil, Eurozone countries, and Canada. Further, Corteva’s largest currency exposures are the Brazilian real, Euro, Canadian dollar and Argentine peso.”
Enlist E3 soybean trait
Technology Dependency

Substantially all branded soybean portfolio uses Enlist E3 trait; leading US soybean herbicide tolerance trait drives seed demand.

Relevance 85·Dependency 70·Confidence 93
Source evidence
“substantially all of the company's branded soybean portfolio offers the Enlist E3® trait, in proprietary Corteva germplasm.”
Chlorinated pyridines derivatives and active ingredients
Supplier Dependency

Crop Protection depends on a few major suppliers for certain important raw materials under long-term contracts, sometimes with minimum purchase commitments.

Relevance 85·Dependency 70·Confidence 94
Source evidence
“Certain important raw materials are supplied by a few major suppliers.”
Pioneer agency model
Revenue Exposure

Pioneer agency model is a unique direct-to-farmer sales channel providing real-time insight into customer ordering decisions.

Relevance 85·Dependency 60·Confidence 95
Source evidence
“The Pioneer agency model is unique to Corteva and represents sales made directly to farmers primarily via independent sales representatives.”
Manufacturing raw materials
Cost Driver

Manufacturing processes consume significant raw materials whose costs are subject to global supply/demand; variations affect operating results.

Relevance 80·Dependency 75·Confidence 95
Source evidence
“Corteva’s manufacturing processes consume significant amounts of raw materials, the costs of which are subject to worldwide supply and demand as well as other factors beyond Corteva’s control.”
Corn and soybean seeds
Supplier Dependency

Seed segment's key raw materials are corn and soybean seeds produced by contracted third-party growers globally.

Relevance 80·Dependency 75·Confidence 95
Source evidence
“The key raw materials for the Seed segment include corn and soybean seeds. To produce high-quality seeds, the company contracts with third-party growers globally.”
USD
Currency Exposure

Corteva hedges FX exposures with derivatives and reports in USD with foreign subsidiaries in highly inflationary environments using USD as functional currency.

Relevance 80·Dependency 70·Confidence 90
Source evidence
“The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices.”
Financial institution customer financing programs (US, Latin America, Europe, Asia)
Revenue Exposure

Sales of seed and crop protection products depend on annual renewal of third-party financing programs; failure to renew would negatively impact sales.

Relevance 80·Dependency 70·Confidence 90
Source evidence
“If Corteva is unable to renew these agreements or access the debt markets to support customer financing, Corteva's sales may be negatively impacted”
Bayer
Legal Exposure

Resolution of litigation with Bayer drove a $610M pre-tax charge in 2025, excluded from segment operating EBITDA.

Relevance 80·Dependency 40·Confidence 95
Source evidence
“Consists of a charge relating to the resolution of litigation with Bayer.”
Global contract manufacturers
Manufacturing Dependency

Crop Protection relies on domestic and international contract manufacturers for key formulation inputs, with formulation generally close to end customers.

Relevance 75·Dependency 65·Confidence 90
Source evidence
“The company relies on contract manufacturers, both domestically and internationally, to produce certain inputs or key components for its product formulations.”
Tariffs and trade policy
Geopolitical Exposure

Retaliatory tariffs and trade restrictions can reduce exports and raise manufacturing input costs.

Relevance 75·Dependency 60·Confidence 90
Source evidence
“other countries retaliating by purchasing less from the United States and the imposition of their own trade restrictions and/or increased tariffs in response to substantial changes to U.S. tariff, trade and tax policies.”
Food Supply Chain Security executive order / antitrust enforcement
Legal Exposure

DOJ/FTC task forces and pending FTC/state AG lawsuits may impose fines, penalties, or practice restrictions and limit M&A growth opportunities.

Relevance 75·Dependency 60·Confidence 95
Source evidence
“Antitrust and competition enforcement actions, including the current FTC and related state attorney general lawsuits pending against Corteva, may result in regulators imposing fines, penalties, or restrictions on a company’s business practices”
Trait and germplasm licensing
Revenue Exposure

Corteva out-licenses traits and germplasm to third parties, including Conkesta E3 adoption growth in Brazil through licensing.

Relevance 70·Dependency 55·Confidence 90
Source evidence
“In Brazil, growth in adoption of Conkesta E3® soybean technology is being pursued through licensing.”
Biologicals product line
Demand Driver

Biologicals and nature-based products are a strategic growth focus for the Crop Protection segment.

Relevance 70·Dependency 50·Confidence 85
Source evidence
“plans to grow through its differentiated, sustainable product offerings, including biologicals”
Chlorine and technical grade active ingredients
Cost Driver

Chlorine, chlorinated pyridines derivatives, and technical active ingredients are key inputs; company expects raw material markets to remain balanced.

Relevance 65·Dependency 60·Confidence 85
Source evidence
“The company expects the markets for its raw materials to remain balanced.”
Input costs and inflation
Cost Driver

CODM explicitly monitors input costs and inflationary and currency impacts when evaluating segment performance.

Relevance 65·Dependency 50·Confidence 88
Source evidence
“evaluating the impacts of market-driven trends on segment performance, such as input costs and inflationary and currency impacts”
Inari
Legal Exposure

IP challenges involving Inari create uncertainty over Corteva's intellectual property value and R&D investment returns.

Relevance 60·Dependency 40·Confidence 85
Source evidence
“Competitors are increasingly challenging intellectual property positions and the outcomes to these challenges, including those with Inari, can be highly uncertain”
Intermediary distribution platform / counterfeit products
Competitive Exposure

Competitor intermediary distribution platforms and counterfeit products are disclosed risks affecting Corteva's go-to-market.

Relevance 55·Dependency 45·Confidence 80
Source evidence
“(ix) competitor's establishment of an intermediary platform for distribution of the company's products; (xxiv) effect of counterfeit products;”
United States
Demand Driver

Funding and staff reductions at U.S. government agencies are disclosed as a risk that could affect Corteva's business.

Relevance 55·Dependency 40·Confidence 80
Source evidence
“(x) risks related to recent funding and staff reductions at U.S. government agencies;”
Full company information
Latest profile, trading, valuation, and identifier data stored for CTVA.
Share price
$11.78
Market cap
$7.86B
Exchange
NYSE
Currency
USD
CEO
Luke C. Kissam
Employees
21,500
IPO date
24/05/2019
Beta
0.588
Last dividend
$0.00
Day range
$11.72 – $12.03
52-week range
$9.19 – $14.62
1-day performance
-1.22%
1-year performance
28.13%
Current drawdown (1Y)
-19.46%
CIK
0001755672
CUSIP
22052L104
ISIN
US22052L1044
Created
07/12/2025, 03:29:15
Last update
03/11/2026, 19:39:07

Track Corteva, Inc. with an AI analyst

See which prediction-market events move CTVA, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to CTVA from your Railway `news_articles` table.